Results 71 to 80 of about 10,632 (179)

Cardiovascular adverse events during treatment with darunavir-based regimens in an Italian observational study

open access: yesDrug Design, Development and Therapy, 2019
A Antinori,1 S Rusconi,2 N Gianotti,3 T Bini,4 D Mancusi,5 R Termini51HIV/AIDS Department, National Institute for Infectious Diseases “Lazzaro Spallanzani” IRCCS, Rome, Italy; 2Infectious Diseases Unit, DIBIC Luigi Sacco, University of Milan,
Antinori A   +5 more
doaj  

Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial. [PDF]

open access: yesNat Commun
Català-Moll F   +16 more
europepmc   +1 more source

Effectiveness and safety of darunavir and lopinavir for treating children and adolescents living with HIV: a systematic review. [PDF]

open access: yesBMC Infect Dis
O'Rourke J   +10 more
europepmc   +1 more source

Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancy. [PDF]

open access: yesAIDS
Sconza R   +8 more
europepmc   +1 more source

Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial. [PDF]

open access: yesNat Commun
Català-Moll F   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy